Literature DB >> 4814601

Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxide.

J Koch-Weser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4814601     DOI: 10.1007/bf01927714

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  16 in total

1.  HYDRALAZINE IN HYPERTENSION.

Authors:  E D FREIS
Journal:  Am Heart J       Date:  1964-01       Impact factor: 4.749

2.  Acute circulatory effects of diazoxide and sodium nitrite.

Authors:  A A RUBIN; L ZITOWITZ; L HAUSLER
Journal:  J Pharmacol Exp Ther       Date:  1963-04       Impact factor: 4.030

3.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

4.  Pharmacology of diazoxide, an antihypertensive, nondiuretic benzothiadiazine.

Authors:  A A RUBIN; F E ROTH; R M TAYLOR; H ROSENKILDE
Journal:  J Pharmacol Exp Ther       Date:  1962-06       Impact factor: 4.030

5.  Mode of action of hydralazine on guinea pig atria.

Authors:  M E Gershwin; N T Smith
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-11

6.  The effect of selective cardiac adrenergic beta-blockade on the hypotensive effect of hydrallazine.

Authors:  A S Dahr; C F George; C T Dollery
Journal:  Experientia       Date:  1971-05-15

7.  Vasodilation for vasopastic hypertension.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

8.  Characteristics and mechanism of inotropic and chronotropic actions of bretylium tosylate.

Authors:  J E Markis; J Koch-Weser
Journal:  J Pharmacol Exp Ther       Date:  1971-07       Impact factor: 4.030

9.  Relation of hydralazine plasma concentration to dosage and hypotensive action.

Authors:  R Zacest; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

10.  Protein binding and vascular activity of diazoxide.

Authors:  E M Sellers; J Koch-Weser
Journal:  N Engl J Med       Date:  1969-11-20       Impact factor: 91.245

View more
  3 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

3.  Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.

Authors:  J Mehta; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1978-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.